Elyse Watkins, DHSc, PA-C, DFAAPA
Epistaxis, the most common otologic emergency, is responsible for one in 200 emergency department (ED) visits in the United States (US) and one-third of otolaryngology visits.1
Up to 60% of the population will experience epistaxis during their lifetime and 6% -10% will require medical intervention.2,3 Epistaxis occurs in children and adults and has a seasonal variation. Although 85% of nosebleeds are idiopathic, they are more frequent in those on supplemental oxygen, anticoagulation, antiplatelet therapy, and in those with other conditions that may predispose them to bleed. Most clinicians will encounter patients with acute epistaxis and therefore it is vitally important to be educated on the etiology, prevention, and acute management. This CME article will review the new Clinical Practice Guidelines4 from the American Academy of Otolaryngology-Head and Neck Surgery regarding epistaxis and discuss newer therapies that have emerged.
Cannell CR. Stop the Bleed! Acute Epistaxis Management. Lynchburg Journal of Medical Science. 2022; 4(2).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.